Skip to content

DeepTCM1.0: A Multi-Expert AI Agent for Deciphering Mechanisms of Chinese Herbal Formulae Based on General Large Language Models

Jun 2026 · 0 citations
Computer Science

TL;DR

The DeepTCM1.0 framework was applied to the mechanistic interpretation of Guizhi Decoction from the dual perspectives of classical traditional Chinese medicine theory and modern scientific research, enabling systematic and interpretable mechanistic analysis of TCM compound formulas.

Abstract

Background: Mechanistic elucidation of traditional Chinese medicine (TCM) compound formulas remains a central challenge in the modernization of TCM. Conventional approaches, including data mining and network pharmacology, are insufficient for achieving deep integration between classical TCM theory and modern scientific research. In addition, direct question-answering using general-purpose artificial intelligence large language models is limited by inadequate adaptation to TCM theoretical frameworks and susceptibility to reasoning hallucinations. Consequently, there is an urgent need to develop intelligent analytical methods aligned with the holistic principles of TCM. Objective: To establish a multi-expert intelligent agent framework integrating classical TCM theory with modern life sciences, thereby enabling systematic and interpretable mechanistic analysis of TCM compound formulas, with Guizhi Decoction serving as a representative validation case. Methods: The DeepTCM1.0 framework was constructed based on the general-purpose large language model DeepSeek V3.2. It adopts a three-tier collaborative architecture and a three-round iterative quality-control workflow, simulating the collaborative analytical process of 11 interdisciplinary intelligent agents. The framework was applied to the mechanistic interpretation of Guizhi Decoction from the dual perspectives of classical traditional Chinese medicine theory and modern scientific research. Framework performance was comprehensively evaluated through double-blind five-dimensional scoring, intraclass correlation coefficient (ICC) reliability testing, Mann-Whitney U tests, and effect size analysis. The evaluation employed four independent large language models as evaluators, each conducting five rounds of repeated scoring on five anonymized reports, resulting in a total of 100 independent scoring assessments.

View source

Similar papers

Review Open access Aug 2026

Integrated Strategy Combining Real-World Data Mining, Network Pharmacology, and Molecular Docking to Decipher the Mechanism of Action of a Core Herbal Combination for Menopausal Syndrome

The core formula likely exerts therapeutic effects via multi-target mechanisms involving ESR1 and TP53 through key signaling pathways, offering a mechanistic explanation for its clinical efficacy against MPS.

E. Zhang, Ya-Xue Xu, Ping Chen et al. · 0 citations
Review Open access Jul 2026

Research Progress in AI-Assisted Drug Discovery and Development from TCM

The unique advantage of traditional Chinese medicine (TCM) lies in its overall regulatory properties, which makes it particularly promising in the treatment of complex diseases. However, for a long time, the discovery of TCM drugs has been limited by inefficient, experience-driven methods and experimental screening met...

Tianyu Chen · 0 citations
Review Open access Aug 2026

Systematic mapping of artificial intelligence and big data architectures for antidiabetic drug discovery from traditional medical systems

AI and big-data methods are being used to reshape selected stages of antidiabetic ethnopharmacology, particularly candidate prioritization, target prediction, and network-based mechanism generation, however, most evidence remains hypothesis-generating.

R. M. Febriyanti, A. A. Irawan, Ami Tjitraresmi et al. · 0 citations
Open access Jul 2026

TCM-USP: An Adaptive and Interpretable Framework for Rapid, Traceable Preliminary Quantification of Active Constituents in Traditional Chinese Medicines Using Biomimetic Sensor Data

Biomimetic sensors offer a rapid route for estimating active constituent contents in Chinese medicinal materials, but their practical use at procurement sites and production workshops is constrained by small and skewed datasets, repeated task-specific model configuration, and the limited operational traceability of man...

Xuemei Yin, Pengfei Song, Xiao Luo et al. · 0 citations
Aug 2026

XunZi, an AI biologist, reveals disease-modifying targets.

In Parkinson's disease (PD), where complex mechanisms and limited targets hamper therapy development, XunZi identifies aberrant activation of CHK2 and IRAK4 kinases across multiple models and establishes a paradigm-shifting framework to translate fragmented biomedical knowledge and data into actionable therapeutics.

Xinhe Huang, Junhong Qin, Fei Tang et al. · 0 citations

Related blog posts

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.